C4 Therapeutics (CCCC) Earnings Date, Estimates & Call Transcripts $2.48 -0.11 (-4.07%) As of 11:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock C4 Therapeutics Earnings Summary C4 Therapeutics released Q2 2025 earnings on August 7, 2025, reporting an EPS of -$0.37, which topped analysts' consensus estimates of -$0.38 by $0.01. Quarterly revenue was reported to be $6.46 million, above the consensus estimate of $5.24 million. With a trailing EPS of -$1.47, C4 Therapeutics' earnings are expected to decrease next year, from ($1.52) to ($1.70) per share. Latest Q2 Earnings DateAug. 7EstimatedConsensus EPS (Aug. 7) -$0.38 Actual EPS (Aug. 7) -$0.37 Beat By $0.01 Actual Revenue (Aug. 7) $6.46MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get C4 Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on C4 Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCCCC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CCCC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. C4 Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.43-$0.43-$0.43Q3 20251-$0.48-$0.48-$0.48Q4 20251-$0.52-$0.52-$0.52 C4 Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025-$0.38-$0.37+$0.01-$0.37$5.24M$6.46M5/7/2025Q1 2025-$0.48-$0.37+$0.11-$0.37$3.54M$7.20M2/27/2025Q4 2024-$0.44-$0.49 -$0.05-$0.49$4.43M$5.18M10/31/2024--$0.40-$0.35+$0.05-$0.35$5.95M$15.36M8/1/2024--$0.37-$0.26+$0.11-$0.26$6.88M$12.01M5/8/2024Q1 2024-$0.41-$0.41--$0.41$10.93M$3.04M2/22/2024Q4 2023-$0.67-$0.68 -$0.01-$0.68$5.23M$3.26M11/1/2023Q3 2023-$0.65-$0.55+$0.10-$0.55$6.94M$11.07M8/8/2023Q2 2023-$0.74-$0.73+$0.01-$0.73$8.65M$2.66M C4 Therapeutics Earnings - Frequently Asked Questions When did C4 Therapeutics announce their last quarterly earnings? C4 Therapeutics (NASDAQ:CCCC) last announced its quarterly earning data on Thursday, August 7, 2025. Learn more on CCCC's earnings history. Did C4 Therapeutics beat their earnings estimates last quarter? In the previous quarter, C4 Therapeutics (NASDAQ:CCCC) reported ($0.37) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.38) by $0.01. Learn more on analysts' earnings estimate vs. CCCC's actual earnings. How much revenue does C4 Therapeutics generate each year? C4 Therapeutics (NASDAQ:CCCC) has a recorded annual revenue of $35.58 million. How much profit does C4 Therapeutics generate each year? C4 Therapeutics (NASDAQ:CCCC) has a recorded net income of -$105.32 million. CCCC has generated -$1.47 earnings per share over the last four quarters. What is C4 Therapeutics' EPS forecast for next year? C4 Therapeutics' earnings are expected to decrease from ($1.52) per share to ($1.70) per share in the next year. More Earnings Resources from MarketBeat Related Companies REPL Earnings Date PHAT Earnings Date KROS Earnings Date RLAY Earnings Date BCAX Earnings Date TLRY Earnings Date ORGO Earnings Date XNCR Earnings Date MRVI Earnings Date TSHA Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 LifelinePalantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk Production This page (NASDAQ:CCCC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share C4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CCCC Stock Alerts